Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alder Biopharmaceuticals Inc (ALDR)  
$18.88 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 90,000,000
Market Cap: 1.70(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.88 - $18.88
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 296
  Page 4 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Smith Jeffrey T L Sr. VP Translational Medicine   •       –      –    2017-06-20 4 OE $0.99 $579 D/D 585 1,416     -
   Latham John A Chief Scientific Officer   •       –      –    2017-05-31 4 A $13.09 $4,359 D/D 333 242,736     -
   Schatzman Randall C President and CEO   •       •      –    2017-02-09 4 AS $25.03 $750,756 D/D (30,000) 115,172     -
   Schatzman Randall C President and CEO   •       •      –    2017-02-09 4 OE $1.65 $49,500 D/D 30,000 145,172     -
   Litton Mark James Chief Business Officer   •       –      –    2017-01-18 4 AS $23.10 $34,599 D/D (1,498) 99,932     -
   Litton Mark James Chief Business Officer   •       –      –    2017-01-18 4 OE $1.65 $2,472 D/D 1,498 101,430     -
   Litton Mark James Chief Business Officer   •       –      –    2017-01-09 4 AS $23.00 $11,500 D/D (500) 99,932     -
   Litton Mark James Chief Business Officer   •       –      –    2017-01-09 4 OE $1.65 $825 D/D 500 100,432     -
   Litton Mark James Chief Business Officer   •       –      –    2017-01-06 4 AS $23.02 $156,520 D/D (6,800) 99,932     -
   Litton Mark James Chief Business Officer   •       –      –    2017-01-06 4 OE $1.27 $9,113 D/D 6,800 106,732     -
   Litton Mark James Chief Business Officer   •       –      –    2017-01-05 4 AS $23.00 $50,972 D/D (2,216) 99,932     -
   Litton Mark James Chief Business Officer   •       –      –    2017-01-05 4 OE $1.27 $2,803 D/D 2,216 102,148     -
   Latham John A Chief Scientific Officer   •       –      –    2016-12-01 4 AS $22.64 $82,812 D/D (3,636) 242,403     -
   Latham John A Chief Scientific Officer   •       –      –    2016-12-01 4 OE $1.65 $5,999 D/D 3,636 246,039     -
   Smith Jeffrey T L Sr. VP Translational Medicine   •       –      –    2016-12-01 4 AS $22.61 $68,328 D/D (3,000) 831     -
   Smith Jeffrey T L Sr. VP Translational Medicine   •       –      –    2016-12-01 4 OE $1.65 $4,950 D/D 3,000 3,831     -
   Benedict Larry EVP and PAO   •       –      –    2016-11-30 4 A $20.20 $14,988 D/D 742 30,989     -
   Schatzman Randall C President and CEO   •       •      –    2016-11-30 4 A $20.20 $8,161 D/D 404 115,172     -
   Latham John A Chief Scientific Officer   •       –      –    2016-11-09 4 AS $30.18 $301,839 D/D (10,000) 242,200     -
   Latham John A Chief Scientific Officer   •       –      –    2016-11-09 4 OE $1.65 $16,500 D/D 10,000 252,200     -
   Schatzman Randall C President and CEO   •       •      –    2016-11-07 4 AS $25.16 $251,605 D/D (10,000) 114,768     -
   Schatzman Randall C President and CEO   •       •      –    2016-11-07 4 OE $1.65 $16,500 D/D 10,000 124,768     -
   Smith Jeffrey T L Sr. VP Translational Medicine   •       –      –    2016-11-01 4 AS $24.26 $73,032 D/D (3,000) 0     -
   Smith Jeffrey T L Sr. VP Translational Medicine   •       –      –    2016-11-01 4 OE $1.65 $4,950 D/D 3,000 3,000     -
   Litton Mark James Chief Business Officer   •       –      –    2016-10-17 4 AS $27.50 $164,998 I/I (6,000) 26,000     -
  296 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us